PRESS RELEASE November 25, 2022 Saniona (OMX: SANION), a clinical stage biopharmaceutical company, today announced the composition of the Nomination Committee for the Annual General Meeting
Three Months Ended September 30, 2022 (2021)Nine Months Ended September 30, 2022 (2021)Revenue was SEK 2.4 M (2.3 M)Revenue was SEK 12.0 M (7.6 M)Operating profit/loss was SEK 21.8 M (-88.2 M)Net profit/loss
Three Months Ended June 30, 2022 (2021)Six Months Ended June 30, 2022 (2021)Revenue was SEK 3.0 M (1.9 M)Revenue was SEK 9.6 M (5.3 M)Operating profit/loss was SEK -91.8 M (-103.6 M)Net profit/loss